AKBA vs POOL · rev $160.2M vs P/E 18, rev $5.31B
Akebia Ther (AKBA) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
AKBA currently screens at market cap $260.1M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the AKBA and POOL stock pages for the full models.
Not investment advice.